[1]
H. Mustikasari, M. Muvida, and L. S. Nugroho, “Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: Factors Affecting Clinical Outcomes”, IJGHR, vol. 7, no. 5, pp. 327-338, Jul. 2025.